Page last updated: 2024-10-24

chlorambucil and Carcinoma, Non-Small Cell Lung

chlorambucil has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ho, SH1
Ali, A1
Chin, TM1
Go, ML1
Gentile, PS1
Woodcock, TM1
Blumenreich, MS1
Epremian, BE1
Seeger, J1
Sheth, SP1
Hamm, JT1
Sherrill, EJ1
Allegra, JC1

Other Studies

2 other studies available for chlorambucil and Carcinoma, Non-Small Cell Lung

ArticleYear
Dioxonaphthoimidazoliums AB1 and YM155 disrupt phosphorylation of p50 in the NF-κB pathway.
    Oncotarget, 2016, Mar-08, Volume: 7, Issue:10

    Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chlorambucil; HEK293 Cells; Humans; Imi

2016
A phase II trial of chlorambucil in non-small cell lung cancer.
    American journal of clinical oncology, 1987, Volume: 10, Issue:6

    Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chlorambucil; Drug Evaluation; Female; Humans; Lung Neo

1987